Probi Digestis® on new markets in Asia


Probi Digestis® to be launched on new markets in Asia

Probi AB, a leading probiotic research and development company from Sweden and DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement for the launch of Probi Digestis® in Hong Kong and Macau.

Read the full release here

Year-End Report 2014


32% growth and higher operating margin for full-year 2014

Read the full release here

Record order for Probi from US company NBTY


Record order for Probi from US company NBTY

Probi has secured its largest order to date, valued at MSEK 17, from the US company NBTY. Probi is to supply probiotic products that will be included in an already well-established consumer product. In the US, demand for well-documented probiotic products is considerable and the market has been growing by 20% plus over the last couple of years.

Read the full release here

Interim Report January – September 2014


Net sales rose 54% to MSEK 37.1 in the third quarter

Read the full release here

New members to the Scientific Advisory Board


Probi appoints Glenn Gibson, Maria Rescigno and Henrik Vestergaard to Scientific Advisory Board

Probi renews its Scientific Advisory Board to further strengthen its Probiotic business by increasing the understanding of the microbiome and its impact on health.

Read the full release here

Probi Digestis® in Brazil


Probi to launch Probi Digestis® in Brazil 

Probi has signed a distribution agreement with Laboratório Daudt, the oldest Brazilian pharmaceutical company with market presence since 130 years. Following registration, Lab. Daudt plans to launch Probi Digestis® during 2015.

Read the full release here

Gun-Britt Fransson, VP R&D, presents at Financial Hearings


Gun-Britt Fransson, Vice President Research & Development, presents Probi at Financial Hearings

Click here for the presentation

Probi and Pharmavite expand collaboration


Probi and Pharmavite expand collaboration in the US and international markets

Probi and Pharmavite have signed a new long-term agreement for distribution and marketing of Probi´s probiotic products. Under the new agreement Pharmavite will broaden the distribution and expand the Nature Made® range with additional probiotic products from Probi. Pharmavite will also expand it´s probiotic business internationally, among other markets, in the Middle East.

Read the full release here

Probi to present at Öresund Investment Day


Probi will be presenting at Öresund Investment Day on September 22nd 2014.

Invitation to Öresund Investment Day with program


This is Probi


This is Probi – a short animated film about Probi